Vaccination clinic begins Tuesday at MD Anderson
Following receipt of the Pfizer COVID-19 vaccine on Monday morning, MD Anderson’s Pharmacy, Infection Control, Employee Health and clinical and facilities experts re-reviewed protocols and procedures, and an initial vaccination clinic simulation was completed. Based on those successful efforts along with a manager briefing and employee town hall, positive feedback from managers about employee engagement and swift uptake of appointment...
Combination of chemotherapy and blinatumomab improves survival for patients with B-cell acute lymphoblastic leukemia
ABSTRACT 464
A study led by The University of Texas MD Anderson Cancer Center showed that first-line treatment with a regimen of chemotherapy...
MD Anderson welcomes 15 volunteer board members, honors two new Life Members
The University of Texas MD Anderson Cancer Center Board of Visitors (BOV) has named 15 new members and bestowed its highest honor of Life...
Patients with advanced BRCA-mutated breast cancer found no overall survival benefit with talazoparib
ABSTRACT: CTO71
New data from the Phase III EMBRACA trial led by researchers at The University of Texas MD Anderson Cancer Center found the PARP inhibitor talazoparib did not demonstrate a statistically significant overall survival (OS) benefit for patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes. Most patients included in the study went on to receive subsequent systemic therapies, which...
MD Anderson genetics expert Guillermina Lozano elected to American Academy of Arts and Sciences
Guillermina Lozano, Ph.D., chair of Genetics at The University of Texas MD Anderson Cancer Center, has been elected as...
Study demonstrates liquid biopsy as effective predictor of stage III melanoma relapse and treatment
A study at The University of Texas MD Anderson Cancer Center showed that circulating tumor cells (CTCs), a form of liquid biopsy, was independently...
MD Anderson’s deemed status restored; re-accreditation completed
The University of Texas MD Anderson Cancer Center has announced that the Texas Health and Human Services Commission, on behalf of the Centers...